Evidence map›Paper›PMID 40628444›Full record

ArticleThe British journal of ophthalmology2025

3D facial reconstruction refines 60-4 visual field assessment.

Armin Garmany, Sepideh Jamali Dogahe, Seyedmostafa Sadegh Mousavi, Tyler M Kaplan, Cheryl L Khanna

Abstract read
In one paragraph

Article in The British journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Armin GarmanyMayo Clinic Medical Scientist Training Program, Mayo Clinic, Rochester, Minnesota, USA.ORCID http://orcid.org/0000-0002-5518-8544
Sepideh Jamali DogaheMayo Clinic Minnesota, Rochester, Minnesota, USA.
Seyedmostafa Sadegh MousaviDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
Tyler M KaplanDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
Cheryl L KhannaDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA Khanna.cheryl@mayo.edu.ORCID http://orcid.org/0000-0002-3735-4297

Funding

MSTP at Mayo Clinic RochesterT32GM145408 · NIGMS · MAYO CLINIC ROCHESTER · PI SCOTT H KAUFMANN, LISA A SCHIMMENTI · 2023 to 2026
$4.7M
NIGMS NIH HHS T32 GM145408
6 · The paper itself

Abstract

backgroundThis study aimed to provide methodology to create a facial contour-informed normative 60-4 visual field and to apply the reference field to a glaucoma cohort to derive facial contour-informed 60-4 global indices.

methodsParticipant recruitment was completed at a tertiary medical centre. 60 eyes from 30 participants with no ocular pathology by clinical exam or optical coherence tomography were recruited for the healthy cohort. For the glaucoma cohort, 86 eyes from 43 patients diagnosed with glaucoma by clinical exam were recruited, with 30-2 visual field mean deviation used to stratify glaucoma severity.

resultsThe median (range) age of the healthy participants was 33 (24-61) years old. A facial contour-informed 60-4 visual field reference field was developed. 43 glaucoma patients were recruited with a resulting median (range) age of 65 (30-84). Three algorithms compensating for facial contour were used for the derivation of 60-4 mean deviation and pattern SD. All mean deviation algorithms correlated with 30-2 mean deviation severity (ρ≤-0.62, p<0.0001) and retinal nerve fibre layer thickness (ρ≥0.36, p<0.05). For pattern SD, consideration of inferior nasal defects allowed correlation with both 30-2 mean deviation severity (ρ≥0.49, p<0.001) and retinal nerve fibre layer thickness (ρ≤-0.47, p<0.01).

conclusionThis study provides methodology for deriving a facial contour-informed 60-4 reference field and illustrates the feasibility of applying facial contour information to refine global indices of the 60-4 visual field. Obtained metrics compensated for facial contour and correlated with functional and structural disease metrics.

Indexed as

FaceGlaucomaImaging, Three-DimensionalVision DisordersVisual FieldsVisual Field TestsAdultAgedAged, 80 and overAlgorithmsFemaleHumansIntraocular PressureMaleMiddle AgedNerve FibersDiagnostic tests/InvestigationField of visionGlaucoma

Identifiers

PMID40628444
PMCPMC12551758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.